Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06701214 · ClinicalTrials.gov registry record
The Clonal Hematopoiesis & Inflammation in Vasculature Registry and Biorepository
A clinical trial of Clonal Hematopoiesis, sponsored by Vanderbilt-Ingram Cancer Center.
- Recruiting
- Registry status
- 800
- Enrollment target
- 1
- Study location
NCT06701214: Recruiting study of Clonal Hematopoiesis, sponsored by Vanderbilt-Ingram Cancer Center.
NCT06701214 is a study of Clonal Hematopoiesis that is actively recruiting participants, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 800 participants, below the 1,230-participant average among 3 other Clonal Hematopoiesis trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06701214, a study of Clonal Hematopoiesis, is actively recruiting participants, sponsored by Vanderbilt-Ingram Cancer Center.
- RECRUITING
- Registry status
- 800 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will investigate the association between clonal hematopoiesis and other conditions. Clonal hematopoiesis (CH) refers to the mutations in a person's stem cells which commonly affect people as they get older. These mutations have notably been linked to increased risk of certain cancers as well as increased risk of heart disease.
Primary Outcome
Aggregate data will be utilized to better understand the association between clonal hematopoiesis and other conditions
Conditions Studied
Interventions
- OTHER Blood collection
- OTHER Bone marrow collection
- OTHER Saliva collection
Study Locations (1)
Tennessee
- Vanderbilt University/Ingram Cancer Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2020-10-28 |
| Est. Completion | 2031-11-30 |
What NCT06701214 shows while recruiting
NCT06701214 is an observational study that tracks outcomes without assigning an intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, below the 1,230-participant average among 3 other Clonal Hematopoiesis trials with a reported enrollment target (35% lower).
The record links to 1 condition, with Clonal Hematopoiesis appearing as the primary indexed condition, and to 3 interventions - of which Blood collection is the first listed.
NCT06701214 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT06701214 about?
NCT06701214 is a clinical study titled "The Clonal Hematopoiesis & Inflammation in Vasculature Registry and Biorepository". This study will investigate the association between clonal hematopoiesis and other conditions. Clonal hematopoiesis (CH) refers to the mutations in a person's stem cells which commonly affect people as they get older. These mutations have notably been linked to increased risk of certain cancers as w...
What is the current status of trial NCT06701214?
This trial is currently recruiting. The enrollment target is 800 participants. The study started on 2020-10-28. Estimated completion is 2031-11-30.
What conditions does trial NCT06701214 study?
This clinical trial studies the following conditions: Clonal Hematopoiesis.
What interventions are being tested in trial NCT06701214?
The interventions under investigation include: Blood collection (OTHER), Bone marrow collection (OTHER), Saliva collection (OTHER).
Who is sponsoring clinical trial NCT06701214?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06701214 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Clonal Hematopoiesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI